InvestorsHub Logo

DonMauri

08/22/07 11:56 AM

#604 RE: bookert #603

Anybody who holds the position will get free shares!
That should be a good motivation of a stock that can reach the moon!

skully

08/23/07 9:25 AM

#608 RE: bookert #603

You can believe whatever you want .....
I'll let you CHEW on this ....

Vancouver, BC – March 19, 2007 – Octillion Corp. (Symbol: OCTL),
a technology incubator focused on the identification,
acquisition, and eventual commercialization of emerging
technologies, is pleased to announce the appointment of
Mr. Harmel S. Rayat, a long-term shareholder and current
Director, to the position of President and Chief Executive Officer.

The NEXT section was taken from here ....

http://www.citronresearch.com/index.php?s=harmel+rayat

----------------------------------------------------------
Hepalife (HPLF)
Shares Outstanding- 53,613,332
Market Capitalization- $140,000,000
Cash in Bank- $63,000

Hepalife is a company that is supposed to discover the artificial liver. with $63k in the bank. Scott Fraser was given a budget of over $300k to promote Hepalife in his newsletter.

Hepalife is the latest deal by Vancouver Stock Promoter Harmel Rayat. Mr. Rayat is the majority shareholder of Hepalife. Who is Mr. Rayat? Ask the Securites and Exchange Commission. http://www.sec.gov/litigation/litreleases/lr16662.htm.

HE IS A STOCK PROMOTER

As a matter of fact, the offices of Hepalife are the same offices as were those for EquityAlert.com, Mr. Rayat’s promotion company.

For that matter, the offices of Hepalife are shared with four other companies that Harmel Rayat controls. Let’s see how these companies are doing so we can guess the fate of HPLF. All of the below companies share the same small office with Hepalife at 1628 West 1st Avenue, Suite 216 Vancouver, CA.

ETHO- .25
ETPT- .24
EDAN- .25
IPTH- .0001

Rayat and family print more paper (to themselves) than the New York Times.or in his case the Vancouver Sun. Mr. Rayat has issued himself and his family TENS of MILLION of S-8 shares of HPLF, options and warrants at an average of $0.07

Who is the new President/CEO?
On September 23, 2003 Hepalife announced that Mr. Arian Soheili is the new President/CEO of Hepalife. Is he a researcher? Is he a Doctor? Is he a liver specialist? No, he is a front man for Harmel Rayat.

Mr. Soheili used to be the treasurer, secretary, and director of Biommune (BIMM).now trading at .0001. The Rayat family were major shareholders in Biommune. And in order to keep the streak going, Biommune had a dubious history with the SEC for putting out false news to the public.
http://www.sec.gov/litigation/admin/34-43246.htm